Back to funds
View filing
Bain Capital Life Sciences Investors, LLC
Updated 6 days agoManaged by Bain Capital Life Sciences Investors, Llc • Latest filing Q3 2026
Portfolio value
$1.5B
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 4 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q4 2025 | $1.3B |
| Q1 2026 | $1.1B |
| Q2 2026 | $1.7B |
| Q3 2026 | $1.5B |
Top holdings
23 positions as of Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | $257.9M | 22.58M | 17.31% | — | |
| 2 | $221.3M | 4.45M | 14.85% | — | |
| 3 | $134.2M | 6.73M | 9.01% | — | |
| 4 | $127.7M | 3.15M | 8.57% | — | |
| 5 | $92.6M | 3.81M | 6.21% | — | |
| 6 | $90.8M | 17.60M | 6.10% | — | |
| 7 | $86.2M | 1.10M | 5.78% | — | |
| 8 | $76.9M | 2.48M | 5.16% | — | |
| 9 | $70.9M | 9.81M | 4.76% | — | |
| 10 | $61.2M | 7.09M | 4.11% | — | |
| 11 | $50.9M | 1.65M | 3.42% | — | |
| 12 | $40.7M | 21.21M | 2.73% | — | |
| 13 | $37.3M | 2.37M | 2.50% | — | |
| 14 | $30.6M | 1.90M | 2.05% | — | |
| 15 | $23.9M | 7.17M | 1.60% | — | |
| 16 | ? N/A X4 PHARMACEUTICALS INC | $23.1M | 7.97M | 1.55% | — |
| 17 | $18.8M | 4.44M | 1.26% | — | |
| 18 | $10.8M | 2.08M | 0.73% | — | |
| 19 | $9.2M | 141.2K | 0.62% | — | |
| 20 | ? N/A KYVERNA THERAPEUTICS INC | $8.9M | 1.31M | 0.60% | — |